To address the question of how gene expression is de-regulated in t(6;9) AML, we assessed chromatin accessibility using DNaseI-seq and gene expression by RNA-seq in CD34-purified AML blasts from two t(6;9)-positive patients and a t(6;9) cell line, FKH1. The gene discussed is CD34; the disease is acute myeloid leukemia.